News from REMEDY

How can patients with rheumatic diseases receive better and safer treatment? This has been a central question throughout Espen A. Haavardsholm's research career. Now he has been awarded the Gleditsch Prize.

In this webinar, Kelsey Collins, PhD, presents emerging research into how adipose tissue, hormones and metabolism may influence osteoarthritis, joint damage and pain.

The title of the PhD thesis is Treatment effectiveness, health-related quality of life and long-term outcomes in adults with juvenile idiopathic arthritis

A new Norwegian study estimates that 60 percent vaccine uptake could result in 2,550 fewer cases of shingles per 10,000 people with rheumatoid arthritis after the age of 50. It also estimates 1,303 fewer cases of long-term nerve pain. The vaccine is not publicly covered.

Getting a scientific article published is just the first step. For research to have any impact, someone has to read it, understand it, trust the results, and use the knowledge. That was the main message when Professor and Journal Editor Michael Bretthauer met with the researchers in REMEDY, when WP1 invited them to a seminar.

When researchers, therapists and patients meet, new knowledge can become both more relevant and easier to understand. On Tuesday, September 22, 2026, the Norwegian Rheumatology Association, Diakonhjemmet Hospital and the REMEDY research center invite you to the annual free event, the Dialogue Seminar.

A large study of almost 39,000 patients shows clear differences between European countries. In wealthier countries, patients started treatment earlier – but also switched more quickly.

Digital treatment tools can be developed, validated and researched without being made available to patients. During Arendal Week, participants pointed out obstacles related to regulations, procurement, financing, legal assessments and the responsibility for achieving national dissemination.

You are hereby invited to MUSS, an interdisciplinary conference with two eventful days of exciting lectures. The conference is relevant for researchers, healthcare professionals, users, clinicians and others interested in musculoskeletal health. Participation in the conference gives you an opportunity to network and be inspired by others who share your interest in the field.

Digital health tools that work are rarely used on a large scale. Now the government wants to give them a place on par with pharmaceuticals and other health technology. How will this happen, who will pay – and how long will patients have to wait? This will be discussed during Arendal Week.

This year's Green Congress brought together researchers, clinicians and professionals to summarize the research presented at EULAR 2026. The goal was to highlight knowledge with significance for patients, practitioners and research communities alike. This is a communications consultant's attempt to summarize some of the main points from the event.